{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:09:18Z","timestamp":1778843358555,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002657","name":"Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002657","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.msard.2024.106238","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T03:12:08Z","timestamp":1734664328000},"page":"106238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Differentiating multiple sclerosis with predominant spinal cord and optic nerve involvement from other autoimmune demyelinating diseases using B cell immunophenotyping and gene expression profiling"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4809-2966","authenticated-orcid":false,"given":"Vuslat","family":"Yilmaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zerrin","family":"Karaaslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"Sanli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hande","family":"Yuceer-Korkmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canan Aysel","family":"Ulusoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zlem","family":"Timirci-Kahraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuncay","family":"Gunduz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Kurtuncu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asli","family":"Tuncer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Recai","family":"Turkoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasemin","family":"Gursoy-Ozdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cem Ismail","family":"Kucukali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdem","family":"Tuzun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.msard.2024.106238_bib0001","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00415-010-5780-4","article-title":"Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients","volume":"258","author":"Akman-Demir","year":"2011","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2024.106238_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2021.152113","article-title":"Reduced frequency and functional potency of CD49d- T regulatory cells in patients with newly diagnosed type 2 diabetes mellitus","volume":"226","author":"Borzouei","year":"2021","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.msard.2024.106238_bib0003","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2249.2000.01334.x","article-title":"Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions","volume":"122","author":"Boven","year":"2000","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.msard.2024.106238_bib0004","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.msard.2024.106238_bib0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1179\/016164106X98107","article-title":"The role of CD4+ T-cells in the development of MS","volume":"28","author":"Delgado","year":"2006","journal-title":"Neurol. Res."},{"issue":"3","key":"10.1016\/j.msard.2024.106238_bib0006","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(08)70042-5","article-title":"Environmental factors and multiple sclerosis","volume":"7","author":"Ebers","year":"2008","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.msard.2024.106238_bib0007","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1756285611400658","article-title":"Symptomatic therapy in multiple sclerosis","volume":"4","author":"Frohman","year":"2011","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"1","key":"10.1016\/j.msard.2024.106238_bib0008","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1038\/s41467-019-12160-2","article-title":"B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma","volume":"10","author":"Griss","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.msard.2024.106238_bib0009","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.0105-2896.2005.00240.x","article-title":"Multiple sclerosis","volume":"204","author":"Hafler","year":"2005","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.msard.2024.106238_bib0010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ncpneuro0154","article-title":"Immunopathogenesis and immunotherapy of multiple sclerosis","volume":"2","author":"Hemmer","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2024.106238_bib0011","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.fsi.2013.09.020","article-title":"The biofunction of orange-spotted grouper (Epinephelus coioides) CC chemokine ligand 4 (CCL4) in innate and adaptive immunity","volume":"35","author":"Hsu","year":"2013","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.msard.2024.106238_bib0012","article-title":"Single-cell RNA sequencing reveals cell type-specific immune regulation associated with human neuromyelitis optica spectrum disorder","volume":"15","author":"iang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2024.106238_bib0013","article-title":"Single-cell RNA sequencing reveals cell type-specific immune regulation associated with human neuromyelitis optica spectrum disorder","volume":"15","author":"Jiang","year":"2024","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.msard.2024.106238_bib0014","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000053777","article-title":"Chemokines, chemokine receptors and allergy","volume":"124","author":"Kaplan","year":"2001","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.msard.2024.106238_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104940","article-title":"Chloride intracellular channel protein-1 (CLIC1) antibody in multiple sclerosis patients with predominant optic nerve and spinal cord involvement","volume":"78","author":"Karaaslan","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.msard.2024.106238_bib0016","first-page":"341","article-title":"Serum CXCL5 as a biomarker in multiple sclerosis and neuromyelitis optica spectrum disorder","volume":"10","author":"Karaaslan","year":"2023","journal-title":"North. Clin. Istanb."},{"issue":"5","key":"10.1016\/j.msard.2024.106238_bib0017","first-page":"1176","article-title":"Phenotypic identification of CD19+CD5+CD1d+ regulatory B cells that produce interleukin 10 and transforming growth factor \u03b21 in human peripheral blood. Archives of medical science","volume":"15","author":"Karim","year":"2019","journal-title":"AMS"},{"issue":"4","key":"10.1016\/j.msard.2024.106238_bib0018","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4168\/aair.2022.14.4.424","article-title":"Interleukin-18 Receptor \u03b1 Modulates the T Cell Response in Food Allergy","volume":"14","author":"Kim","year":"2022","journal-title":"Allerg. Asthm. Immunol. Res.,"},{"issue":"624","key":"10.1016\/j.msard.2024.106238_bib0019","doi-asserted-by":"crossref","first-page":"eabk2132","DOI":"10.1126\/scitranslmed.abk2132","article-title":"Functional impairment of CD19+CD24hiCD38hi B cells in neuromyelitis optica spectrum disorder is restored by B cell depletion therapy","volume":"13","author":"Kim","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.msard.2024.106238_bib0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/09612033211069853","article-title":"Elevated serum free IL-18 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders","volume":"31","author":"Liang","year":"2022","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.msard.2024.106238_bib0021","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12974-021-02266-0","article-title":"Regulatory T cells protect against brain damage by alleviating inflammatory response in neuromyelitis optica spectrum disorder","volume":"18","author":"Ma","year":"2021","journal-title":"J Neuroinflammation"},{"issue":"3","key":"10.1016\/j.msard.2024.106238_bib0022","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.bbrc.2015.07.038","article-title":"Anti-infective peptide IDR-1002 augments monocyte chemotaxis towards CCR5 chemokines","volume":"464","author":"Madera","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.msard.2024.106238_bib0023","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/15525","article-title":"A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor","volume":"23","author":"Madsen","year":"1999","journal-title":"Nat. Genet."},{"issue":"Pt 4","key":"10.1016\/j.msard.2024.106238_bib0024","first-page":"1089","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain: J. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2024.106238_bib0025","doi-asserted-by":"crossref","first-page":"e61835","DOI":"10.1371\/journal.pone.0061835","article-title":"Characteristic cerebrospinal fluid cytokine\/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis","volume":"8","author":"Matsushita","year":"2013","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.msard.2024.106238_bib0026","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1359-6101(02)00045-X","article-title":"Macrophage inflammatory protein-1","volume":"13","author":"Menten","year":"2002","journal-title":"Cytokine Grow. Fact. Rev."},{"issue":"7","key":"10.1016\/j.msard.2024.106238_bib0027","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.autrev.2016.03.006","article-title":"Therapeutic strategies targeting B-cells in multiple sclerosis","volume":"15","author":"Milo","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"10","key":"10.1016\/j.msard.2024.106238_bib0028","doi-asserted-by":"crossref","first-page":"12213","DOI":"10.3390\/ijms131012213","article-title":"Interferon-\u03b21b increases Th2 response in neuromyelitis optica","volume":"13","author":"Nakajima","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.msard.2024.106238_bib0029","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.4049\/jimmunol.177.11.7531","article-title":"CCR4 is a key modulator of innate immune responses","volume":"177","author":"Ness","year":"2006","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/j.msard.2024.106238_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104239","article-title":"Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios","volume":"68","author":"Oezguen","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.msard.2024.106238_bib0031","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1365-2249.2002.01779.x","article-title":"Elevated expression of CCR5 by myeloid (CD11c+) blood dendritic cells in multiple sclerosis and acute optic neuritis","volume":"127","author":"Pashenkov","year":"2002","journal-title":"Clin. Exp. Immunol."},{"issue":"9","key":"10.1016\/j.msard.2024.106238_bib0032","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/jid.2011.127","article-title":"CCL4L polymorphisms and CCL4\/CCL4L serum levels are associated with psoriasis severity","volume":"131","author":"Pedrosa","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.msard.2024.106238_bib0033","article-title":"Letter to the Editor: seronegative NMOSD patients display distinctive peripheral blood T cell subset frequencies","author":"Sanli","year":"2024","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.msard.2024.106238_bib0034","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/10790268.2019.1666238","article-title":"Cytokine-chemokine and cognitive profile of multiple sclerosis patients with predominant optic nerve and spinal cord involvement","volume":"44","author":"\u015een","year":"2021","journal-title":"J. Spinal Cord. Med."},{"issue":"7","key":"10.1016\/j.msard.2024.106238_bib0035","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/08916934.2013.796938","article-title":"Optical neuritis induced by different concentrations of myelin oligodendrocyte glycoprotein presents different profiles of the inflammatory process","volume":"46","author":"Soares","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.msard.2024.106238_bib0036","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.msard.2024.106238_bib0037","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3892\/mmr.2022.12601","article-title":"RGMa regulates CCL5 expression via the BMP receptor in experimental autoimmune encephalomyelitis mice and endothelial cells","volume":"25","author":"Tang","year":"2022","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.msard.2024.106238_bib0038","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00415-002-0699-z","article-title":"Multiple sclerosis and optic neuritis: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal fluid","volume":"249","author":"Teleshova","year":"2002","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2024.106238_bib0039","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"699","key":"10.1016\/j.msard.2024.106238_bib0040","doi-asserted-by":"crossref","first-page":"eadf3843","DOI":"10.1126\/scitranslmed.adf3843","article-title":"Neutrophil extracellular trap production and CCL4L2 expression influence corticosteroid response in asthma","volume":"15","author":"Tsai","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.msard.2024.106238_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103019","article-title":"Peripheral blood B cell subset ratios and expression levels of B cell-associated genes are altered in benign multiple sclerosis","volume":"52","author":"Turkoglu","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2024.106238_bib0042","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2024.106238_bib0043","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/ijms20030649","article-title":"Interleukin-18 in health and disease","volume":"20","author":"Yasuda","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.msard.2024.106238_bib0044","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/CIRCULATIONAHA.121.056730","article-title":"Identification of pathogenic immune cell subsets associated with checkpoint inhibitor-induced myocarditis","volume":"146","author":"Zhu","year":"2022","journal-title":"Circulation"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824008149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824008149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:29:45Z","timestamp":1778840985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824008149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":44,"alternative-id":["S2211034824008149"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.106238","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differentiating multiple sclerosis with predominant spinal cord and optic nerve involvement from other autoimmune demyelinating diseases using B cell immunophenotyping and gene expression profiling","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.106238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106238"}}